PainCeptor Pharma Corp: Series B $20.8M

PainCeptor (Canada) a drug company focused on the treatment of chronic and acute pain raised a $20.8M Series B round. The deal was lead by Desjardins Venture Capital, CDP Capital, T2C2 Capital, Business Development Bank of Canada and Lothian Partners.

Horizon Therapeutics, Inc.: Series B $15M

Horizon Therapeutics (Palo Alto, CA) a late stage biopharmaceutical company focused on development of drugs for pain relief has raised $15M in Series B funding. The deal was lead by Scale Venture Partners, and joined by return backers Sutter Hill Ventures and Pequot Ventures.